These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8829954)

  • 1. Progression and regression of the atherosclerotic plaque.
    de Feyter PJ; Vos J; Deckers JW
    Eur Heart J; 1995 Aug; 16 Suppl I():26-30. PubMed ID: 8829954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retardation of coronary atherosclerosis: the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT) and other angiographic trials.
    de Faire U; Ericsson CG; Grip L; Nilsson J; Svane B; Hamsten A
    Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():257-63. PubMed ID: 9211018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary preventive potential of lipid-lowering drugs. The Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT).
    de Faire U; Ericsson CG; Grip L; Nilsson J; Svane B; Hamsten A
    Eur Heart J; 1996 Dec; 17 Suppl F():37-42. PubMed ID: 8960446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is regression of atherosclerosis possible?].
    Thomas D; Richard JL; Emmerich J; Bruckert E; Delahaye F
    Arch Mal Coeur Vaiss; 1992 Oct; 85 Spec No 3():47-57. PubMed ID: 1296545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease.
    Brown BG; Zhao XQ; Sacco DE; Albers JJ
    Circulation; 1993 Jun; 87(6):1781-91. PubMed ID: 8504494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Can drugs, especially calcium antagonists, bring about regression of atherosclerosis, especially coronary sclerosis?].
    Lichtlen PR
    Schweiz Med Wochenschr; 1991 Dec; 121(49):1807-12. PubMed ID: 1754861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversibility of atherosclerosis--evolving perspectives from two arterial imaging clinical trials: the cholesterol lowering atherosclerosis regression study and the monitored atherosclerosis regression study.
    Hodis HN
    J Cardiovasc Pharmacol; 1995; 25 Suppl 4():S25-31. PubMed ID: 8907211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of coronary atherosclerosis: an achievable goal? Review of results from recent clinical trials.
    Waters D; Lespérance J
    Am J Med; 1991 Jul; 91(1B):10S-17S. PubMed ID: 1867231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposed synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis.
    Jukema JW; van Boven AJ; Zwinderman AH; Van der Laarse A; Bruschke AV
    Cardiovasc Drugs Ther; 1998 Apr; 12 Suppl 1():111-8. PubMed ID: 9642484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP).
    Haskell WL; Alderman EL; Fair JM; Maron DJ; Mackey SF; Superko HR; Williams PT; Johnstone IM; Champagne MA; Krauss RM
    Circulation; 1994 Mar; 89(3):975-90. PubMed ID: 8124838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The relationship between clinical events and the angiographic lesions in coronary atherosclerosis. Hypolipemic treatment and plaque stabilization].
    Castro Beiras A; Vázquez Rodríguez JM; Muñiz J; Calviño R; Vázquez González N; Juane R
    Rev Esp Cardiol; 1995; 48 Suppl 5():23-30. PubMed ID: 7494936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limits of lipid-lowering therapy: the potential benefits of amlodipine as an antiatherosclerotic agent.
    Kramsch DM
    Int J Cardiol; 1997 Dec; 62 Suppl 2():S119-24. PubMed ID: 9488203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoproteins and the progression/regression of atherosclerosis.
    Barth JD
    Baillieres Clin Endocrinol Metab; 1995 Oct; 9(4):849-66. PubMed ID: 8593128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of coronary artery disease predicts clinical coronary events. Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study.
    Azen SP; Mack WJ; Cashin-Hemphill L; LaBree L; Shircore AM; Selzer RH; Blankenhorn DH; Hodis HN
    Circulation; 1996 Jan; 93(1):34-41. PubMed ID: 8616937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of severe atherosclerotic plaque in patients with mild elevation of LDL cholesterol.
    Schaefer S; Hussein H; Gershony GR; Rutledge JC; Kappagoda CT
    J Investig Med; 1997 Dec; 45(9):536-41. PubMed ID: 9444880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs that delay the progression of coronary atherosclerosis.
    Ferraro-Borgida M; Waters D
    Cardiologia; 1997 Feb; 42(2):149-61. PubMed ID: 9090160
    [No Abstract]   [Full Text] [Related]  

  • 17. [Is regression of coronary sclerosis possible?].
    Krayenbühl HP
    Schweiz Rundsch Med Prax; 1993 Nov; 82(47):1348-53. PubMed ID: 8272700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis in symptomatic patients with normal to moderately raised cholesterol levels. The REGRESS Study Group.
    Jukema JW; Zwinderman AH; van Boven AJ; Reiber JH; Van der Laarse A; Lie KI; Bruschke AV
    Arterioscler Thromb Vasc Biol; 1996 Mar; 16(3):425-30. PubMed ID: 8630669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arteriographic view of treatment to achieve regression of coronary atherosclerosis and to prevent plaque disruption and clinical cardiovascular events.
    Brown BG; Zhao XQ; Sacco DE; Albers JJ
    Br Heart J; 1993 Jan; 69(1 Suppl):S48-53. PubMed ID: 8427765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retardation of coronary atherosclerosis with yoga lifestyle intervention.
    Manchanda SC; Narang R; Reddy KS; Sachdeva U; Prabhakaran D; Dharmanand S; Rajani M; Bijlani R
    J Assoc Physicians India; 2000 Jul; 48(7):687-94. PubMed ID: 11273502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.